http://fardj.prblogs.org/2006/09/19/antibiotics-clinical-trials-more-an-interview-with-the-fdas-john-powers-md/ Healthcare, marketing, health policy and more. Fri, 04 Jul 2008 13:02:50 +0000 http://wordpress.org/?v=2.3.3 http://fardj.prblogs.org/2006/09/19/antibiotics-clinical-trials-more-an-interview-with-the-fdas-john-powers-md/#comment-20728 michael zasloff MD,PhD Sat, 30 Jun 2007 00:13:30 +0000 http://fardj.prblogs.org/2006/09/19/antibiotics-clinical-trials-more-an-interview-with-the-fdas-john-powers-md/#comment-20728 Excellent and well articulated argument. Excellent and well articulated argument.

]]> http://fardj.prblogs.org/2006/09/19/antibiotics-clinical-trials-more-an-interview-with-the-fdas-john-powers-md/#comment-4008 Envisioning 2.0 » Blog Archive » FDA Brings In Outside Panel To Reexamine Antibiotic Wed, 15 Nov 2006 15:13:54 +0000 http://fardj.prblogs.org/2006/09/19/antibiotics-clinical-trials-more-an-interview-with-the-fdas-john-powers-md/#comment-4008 [...] - Antibiotics, Clinical Trials & More: An Interview With The FDA’s John Powers, MD [...] […] - Antibiotics, Clinical Trials & More: An Interview With The FDA’s John Powers, MD […]

]]> http://fardj.prblogs.org/2006/09/19/antibiotics-clinical-trials-more-an-interview-with-the-fdas-john-powers-md/#comment-2784 Envisioning 2.0 » Blog Archive » Consumer Driven Healthcare: The Good, Bad and Money; FDA May Be Changing Tune On Antibiotic Trials Tue, 24 Oct 2006 14:39:02 +0000 http://fardj.prblogs.org/2006/09/19/antibiotics-clinical-trials-more-an-interview-with-the-fdas-john-powers-md/#comment-2784 [...] For more information on the FDA’s emerging stance on non-inferiority trials, please see my interview with John Powers, MD. [...] […] For more information on the FDA’s emerging stance on non-inferiority trials, please see my interview with John Powers, MD. […]

]]> http://fardj.prblogs.org/2006/09/19/antibiotics-clinical-trials-more-an-interview-with-the-fdas-john-powers-md/#comment-2688 didimalang bukha Sun, 22 Oct 2006 09:12:59 +0000 http://fardj.prblogs.org/2006/09/19/antibiotics-clinical-trials-more-an-interview-with-the-fdas-john-powers-md/#comment-2688 use of antibiotics by medical private practitioners exposes clients to new expensive and preserved antibiotics and once their medical securities finishes, they are dumped in the main stream where they fail to respond to old antibiotics use of antibiotics by medical private practitioners exposes clients to new expensive and preserved antibiotics and once their medical securities finishes, they are dumped in the main stream where they fail to respond to old antibiotics

]]>